Both in Biotechnology
Tenaya Therapeutics vs LENZ Therapeutics
Over the past year TNYA returned −74.0% and LENZ returned −87.3%; their daily moves had a correlation of 0.30.
TNYA −74.0% LENZ −87.3%Growth of $1, one year, split-adjusted
| Metric | TNYA | LENZ |
|---|---|---|
| Price | $0.3725 | $3.55 |
| Market cap | $84.9M | $111.5M |
| Today | +3.19% | +16.39% |
| 1 month | −34.0% | −1.1% |
| 6 months | −50.6% | −60.9% |
| Year to date | −47.6% | −77.8% |
| 1 year | −74.1% | −88.1% |
| Revenue growth (YoY) | — | +9.7% |
| Gross margin | 100.0% | 94.9% |
| Net margin | −3909.3% | −581.8% |
| P/E (TTM) | — | — |
| Price / sales | 63.6× | 5.2× |
| Net cash | $78.1M | $220.0M |
| Dividend yield | — | — |
| Volatility (60d) | 78.3% | 77.2% |
| Short % of float | 13.1% | 46.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).